Beatriz Vaquerizo

Showing 1-9 of 9 articles

Coronary interventions

Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial

Gomez-Lara J, Salvatella N, Romaguera R, Brugaletta S, Nato M, Roura G, Ferreiro J, Teruel L, Gracida M, Sabaté M, Vaquerizo B, Cequier A, Gomez-Hospital J

June 12, 2020 | 10.4244/EIJ-D-18-01203

Other

Radiation protection measures and sex distribution in European interventional catheterisation laboratories

Manzo-Silberman S, Piccaluga E, Radu M, James S, Schüpke S, Vaquerizo B, Kunadian V, Capranzano P, Mehilli J, Buchanan G, Chieffo A, Mauri Ferre J

May 20, 2020 | 10.4244/EIJ-D-18-01044

Coronary interventions

Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions

Fam J, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, Boukhris M, Vlachojannis G, van Geuns R, Ezhumalai B, Kawamoto H, van der Sijde J, Felix C, Pan M, Serdoz R, Boccuzzi G, De Paolis M, Sardella G, Mancone M, Tamburino C, Smits P, Di Mario C, Seth A, Serra A, Colombo A, Serruys P, Galassi A, Zijlstra F, Van Mieghem N, Diletti R

June 20, 2017 | 10.4244/EIJ-D-16-00253

Coronary interventions

Motivations for and barriers to choosing an interventional cardiology career path: results from the EAPCI Women Committee worldwide survey

Capranzano P, Kunadian V, Mauri Ferre J, Petronio A, Salvatella N, Appelman Y, Gilard M, Mikhail G, Schüpke S, Radu M, Vaquerizo B, Presbitero P, Morice M, Mehilli J

May 16, 2016 | 10.4244/EIJY15M07_03

Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study

Vaquerizo B, Barros A, Pujadas S, Bajo E, Estrada D, Miranda-Guardiola F, Rigla J, Jiménez M, Cinca J, Serra A

September 22, 2015 | 10.4244/EIJY14M12_07

European expert consensus on rotational atherectomy

Barbato E, Carrié D, Dardas P, Fajadet J, Gaul G, Haude M, Khashaba A, Koch K, Meyer-Gessner M, Palazuelos J, Reczuch K, Ribichini F, Sharma S, Sipotz J, Sjögren I, Suetsch G, Szabo G, Valdés Chávarri M, Vaquerizo B, Wijns W, Windecker S, de Belder A

May 19, 2015 | 10.4244/EIJV11I1A6

Failing transcatheter aortic valve treated by transcatheter aortic valve in transcatheter aortic valve (TAV-in-TAV) implantation: valve safety versus valve durability

Vaquerizo B, Martucci G, Buithieu J, de Varennes B, Lachapelle K, Piazza N

December 22, 2014 | 10.4244/EIJV10I8A169

Unprotected left main stenting in the real world: five-year outcomes of the French Left Main Taxus registry

Mylotte D, Meftout B, Moynagh A, Vaquerizo B, Darremont O, Silvestri M, Louvard Y, Leymarie J-L, Morice M, Lefèvre T, Garot P

December 28, 2012 | 10.4244/EIJV8I8A147

ACS and STEMI treatment: gender-related issues

Chieffo A, Buchanan G, Mauri F, Mehilli J, Vaquerizo B, Moynagh A, Mehran R, Morice M

August 25, 2012 | 10.4244/EIJV8SPA6

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.